Showing results (2171-2180 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|November 29, 2015
Circulating Tumor Cells, DNA, and mRNA: Potential for Clinical Utility in Patients With MelanomaMelody J Xu, Jay F Dorsey, Ravi Amaravadi, et al.
The Oncologist|November 29, 2015
Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung CancerDavid D Stenehjem, Brandon K Bellows, Kraig M Yager, et al.
The Oncologist|August 5, 2015
Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma--Analysis Using Diagnostic NodesChristian Rothermundt, Alexandra Bailey, Linda Cerbone, et al.
The Oncologist|August 5, 2015
The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in AsiaHung-Yang Kuo, Zhong-Zhe Lin, Raymond Kuo, et al.
The Oncologist|August 7, 2015
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic CholangiocarcinomaLipika Goyal, Aparna Govindan, Rahul A Sheth, et al.
The Oncologist|August 7, 2015
Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast CancerValentina Guarneri, Maria Vittoria Dieci, Antonio Frassoldati, et al.
The Oncologist|October 9, 2015
Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-AnalysisHong Xu, Kai Chen, Xiaoyan Jia, et al.
The Oncologist|October 9, 2015
Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New HopeFilippo Pietrantonio, Chiara Cremolini, Giuseppe Aprile, et al.
The Oncologist|October 9, 2015
Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective AnalysisYingqiang Zhang, Wenzhe Fan, Yu Wang, et al.
The Oncologist|October 10, 2015
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue SarcomasRodrigo R Munhoz, Sandra P D'Angelo, Mrinal M Gounder, et al.
Pageof 571